Clinical Trial

RADA16 for Adult Tonsillectomy

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage. Participants will: * Undergo tonsillectomy procedure. * Receive and fill out a survey sent via email every 2 days following their procedure for 15 days and track their symptoms.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2025-07-01; most recent amendment 2026-07-21.
Status change: Not Yet Recruiting → Recruiting 2025-10-07
Trial Details
NCT Number NCT07060495
Lead Sponsor Rutgers, The State University of New Jersey
Conditions Postoperative Pain
Enrollment 134 participants
Start Date 2025-09-12
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-23